The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ragozina L.A.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kameleva A.A.

S.S. Yudin City Clinical Hospital

Shuginin I.O.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Kovalenko A.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Kovalenko T.S.

V.I. Krasnopolsky Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Shmakov R.G.

V.I. Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology

Hereditary angioedema and pregnancy. Clinical experience

Authors:

Ragozina L.A., Kameleva A.A., Shuginin I.O., Kovalenko A.A., Kovalenko T.S., Shmakov R.G.

More about the authors

Read: 262 times


To cite this article:

Ragozina LA, Kameleva AA, Shuginin IO, Kovalenko AA, Kovalenko TS, Shmakov RG. Hereditary angioedema and pregnancy. Clinical experience. Russian Bulletin of Obstetrician-Gynecologist. 2025;25(6):77‑82. (In Russ.)
https://doi.org/10.17116/rosakush20252506177

Recommended articles:
The practice of using medi­cal abortion in the world. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):19-24
Acute kidney injury during pregnancy with favo­rable obstetric and nephrological outcome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):65-70
Asplenia — a new cause of thro­mbosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76
The expe­rience of performing metroplasty at placenta accreta in the Repu­blic of Crimea. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):77-81
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Reproductive health of women with hepa­titis C (literature review and own data). Russian Journal of Human Reproduction. 2025;(1):12-20

References:

  1. Bobrikova EN, Denisova AR, Kotomina TS, Serdotetskova SA, Fomina DS. The importance of an individual management plan for patients with hereditary angioedema during pregnancy, lactation, and in newborns. Meditsinskaya immunologiya. 2020;22:3:577-584. (In Russ.). https://doi.org/10.15789/1563-0625-SOI-1930
  2. Demina DV, Makeeva AO, Kudelya LM, Novikova EV, Kozlov VA. Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report. Meditsinskaya immunologiya (Russia). 2020;22:6:1215-1220. (In Russ.). https://doi.org/10.15789/1563-0625-SLP-2062
  3. Russian Association of Allergists and Clinical Immunologists, Union of Pediatricians of Russia, Association of Medical Geneticists, National Association of Experts in Primary Immunodeficiencies. Federal Clinical Guidelines Hereditary Angioedema. 2024. (In Russ.).
  4. Allergology and immunology: national guidelines. Ed. R.M. Khaitov, N.I. Il’ina. M.: GEOTAR-Media. 2014;656. (In Russ.).
  5. Fox J, Vegh AB, Martinez-Saguer I, Wuillemin WA, Edelman J, Williams-Herman D, Rojavin M, Rosenberg T. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema. Allergy Asthma Proc. 2017;38:216-221.  https://doi.org/10.2500/aap.2017.38.4038
  6. Defendi F, Amen A, Clavarino G, Dumestre-Pérard C. C1 inhibitor: from complement system to bradykinin angioedema. Curr Opin Immunol. 2025;97:102653. https://doi.org/10.1016/j.coi.2025.102653
  7. Bouillet L, Lehmann A, Gompel A, Boccon-Gibod I, Launay D, Fain O. Hereditary angioedema treatments: recommendations from the French national center for angioedema (Bordeaux consensus 2014). Presse Med. 2015;44:526-532.  https://doi.org/10.1016/j.lpm.2015.01.005
  8. Riedl MA. Hereditary Angioedema During Pregnancy: Considerations in Management. Immunol Allergy Clin North Am. 2023; 43:1:145-157.  https://doi.org/10.1016/j.iac.2022.05.011
  9. Caballero T, Canabal J, Rivero-Paparoni D, Cabañas R. Management of hereditary angioedema in pregnant women: a review. Int J Womens Health. 2014;6:839-848.  https://doi.org/10.2147/IJWH.S46460
  10. Zotter Z, Csuka D, Szabó E, Czaller I, Nébenführer Z, Temesszentandrási G, Fust G, Varga L, Farkas H. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. Orphanet J Rare Dis. 2014 Mar 28;9:44.  https://doi.org/10.1186/1750-1172-9-44
  11. Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, Caballero T, Drouet C, Farkas H, Massot C, Nielsen EW, Ponard D, Cicardi M. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol. 2008;199:5:484.e1-4.  https://doi.org/10.1016/j.ajog.2008.04.034
  12. Zanichelli A, Wuillemin WA, Aygören-Pürsün E, Banerji A, Busse PJ, Betschel SD, Cancian M, Gagnon R, Goodyear MD, Kinaciyan T, Kessel A, Magerl M, Recke A, Wedner HJ, Estepan DN, Watt M, Andresen I, Juethner S, Khutoryansky N, Martinez-Saguer I. Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence. Ann Allergy Asthma Immunol. 2025;S1081-1206(25)00393-X.  https://doi.org/10.1016/j.anai.2025.07.025
  13. Longhurst HJ. Management of acute attacks of hereditary angioedema: potential role of icatibant. Vasc Health Risk Manag. 2010;6:795-802.  https://doi.org/10.2147/vhrm.s4332
  14. Gabriel N, Marcelino F, Ferriani MPL, Arruda LK, Campos RA, Gonçalves RF, Chong-Neto H, Filho NR, Valle SOR, Pesquero JB, Grumach AS. Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor. Front Allergy. 2022;3:846968. https://doi.org/10.3389/falgy.2022.846968
  15. Jakes AD, Thorne I, Guly J, Kiani-Alikhan S, Banerjee A. Case report: Hereditary angioedema in pregnancy. Obstet Med. 2021; 14:3:177-180.  https://doi.org/10.1177/1753495X20958225
  16. Obtulowicz K, Porebski G, Bilo B, Stobiecki M, Obtulowick A. Hereditary angioedema in pregnancy—case series study. The 6th C1-INH Deficiency Workshop, May 22-24, 2009, Budapest, Hungary, Abstract book: p.58. 
  17. Brunskill PJ. The effects of fetal exposure to danazol. Br J Obstet Gynaecol. 1992;99:212-215.  https://doi.org/10.1111/j.1471-0528.1992.tb14501.x
  18. Prematta M, Gibbs JG, Pratt EL, Stoughton TR, Craig TJ. Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol. 2007;98:383-388.  https://doi.org/10.1016/S1081-1206(10)60886-1
  19. Farkas H, Kőhalmi KV, Veszeli N, Tóth F, Varga L. First report of icatibant treatment in a pregnant patient with hereditary angioedema. J Obstet Gynaecol Res. 2016;42:1026-1028. https://doi.org/10.1111/jog.13003
  20. Visy B, Füst G, Varga L, Szendei G, Takács E, Karádi I, Fekete B, Harmat G, Farkas H. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf). 2004;60:508-515.  https://doi.org/10.1111/j.1365-2265.2004.02009.x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.